Insider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Buys $13,888.32 in Stock

Retractable Technologies, Inc. (NYSE:RVPGet Free Report) CEO Thomas J. Shaw acquired 15,096 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was acquired at an average price of $0.92 per share, with a total value of $13,888.32. Following the completion of the acquisition, the chief executive officer now directly owns 14,629,317 shares of the company’s stock, valued at approximately $13,458,971.64. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.

Retractable Technologies Stock Up 0.8 %

RVP opened at $0.92 on Friday. The firm has a market cap of $27.58 million, a P/E ratio of -3.54 and a beta of 2.08. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The business has a 50 day moving average price of $1.06 and a 200 day moving average price of $1.10. Retractable Technologies, Inc. has a twelve month low of $0.87 and a twelve month high of $1.34.

Retractable Technologies (NYSE:RVPGet Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The firm had revenue of $6.03 million during the quarter.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on Retractable Technologies in a research report on Saturday, August 31st. They issued a “hold” rating for the company.

View Our Latest Report on Retractable Technologies

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Read More

Insider Buying and Selling by Quarter for Retractable Technologies (NYSE:RVP)

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.